Philip Connor

1.8k total citations
24 papers, 545 citations indexed

About

Philip Connor is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Philip Connor has authored 24 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Philip Connor's work include Platelet Disorders and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Philip Connor is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Philip Connor collaborates with scholars based in United Kingdom, United States and Canada. Philip Connor's co-authors include Urbain Säwe, Michael A. Russell, C Feyerabend, G Gustavsson, J A Stapleton, Karsten Lyby, John D. Grainger, Stuart Montgomery, James B. Bussel and Dana C. Matthews and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Philip Connor

21 papers receiving 519 citations

Peers

Philip Connor

HEMAT

PHYSI

PHEOH

GENET

Fernando Hernández Spain

Mai S. Sater Bahrain

Letha E. Mills United States

André W. Broekmans Netherlands

Veerle Labarque Belgium

Preamrudee Poomthavorn Thailand

M.P. Sachdeva India

Soodabeh Safai‐Kutti Sweden

Tatyana Ionova Russia

Tiffany P. Quock United States

Fernando Hernández Spain

Philip Connor

206 ×0.9

HEMAT

104 ×0.8

PHYSI

117 ×1.0

38 ×0.6

PHEOH

89 ×1.5

GENET

Citations per year, relative to Philip Connor Philip Connor (= 1×) peers Fernando Hernández

Countries citing papers authored by Philip Connor

Since Specialization

Citations

This map shows the geographic impact of Philip Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Connor more than expected).

Fields of papers citing papers by Philip Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Connor. The network helps show where Philip Connor may publish in the future.

Co-authorship network of co-authors of Philip Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Connor. A scholar is included among the top collaborators of Philip Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Connor. Philip Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doria‐Rose, V. Paul, Gerard A. Silvestri, Danielle D. Durham, et al.. (2025). The United States’ Early Experience With Lung Cancer Screening—Creation of a National Data Linkage: A Brief Report. JTO Clinical and Research Reports. 6(6). 100825–100825.

Vedi, Aditi, Geoff Shenton, Amélie Trinquand, et al.. (2024). Real‐world experience of paediatric acute promyelocytic leukaemia in the United Kingdom and Ireland. British Journal of Haematology. 206(1). 204–208.

Connor, Philip, Michelle Cummins, Michael Gattens, et al.. (2024). Blinatumomab with De-Escalated Chemotherapy for Infant KMT2A-Rearranged B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 2816–2816. 3 indexed citations

Barnett, S., et al.. (2023). Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report. Cancer Chemotherapy and Pharmacology. 92(4). 325–328.

Kammen, Mayte Sánchez van, Christoph Male, Philip Connor, et al.. (2021). Anticoagulant Treatment for Pediatric Infection-Related Cerebral Venous Thrombosis. Pediatric Neurology. 128. 20–24. 11 indexed citations

Connor, Philip, et al.. (2018). Inherited THPO mutation, with morphology resembling chronic myeloid leukaemia. British Journal of Haematology. 183(3). 344–344. 1 indexed citations

Bussel, James B., Purificación García de Miguel, Jenny M. Despotovic, et al.. (2015). Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. The Lancet Haematology. 2(8). e315–e325. 133 indexed citations

Grainger, John D., et al.. (2014). Thrombopoietin Receptor Agonists in Paediatric ITP Patients: Long Term Follow up Data in 34 Patients. Blood. 124(21). 4206–4206. 7 indexed citations

O’Connor, David, Keith Sibson, Philip Connor, et al.. (2011). Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 154(4). 482–485. 37 indexed citations

10.

Naudé, Johann te Water, et al.. (2010). Neuromyelitis optica complicating autoimmune lymphoproliferative syndrome in a 4‐year‐old girl. British Journal of Haematology. 152(3). 247–247. 6 indexed citations

11.

Connor, Philip, et al.. (2010). Transient abnormal myelopoesis in an infant with Down syndrome. Libyan Journal of Medicine. 5(1). 4635–4635. 1 indexed citations

12.

Parmar, Kiran, Eleftheria Lefkou, Heidi Doughty, Philip Connor, & Beverley J. Hunt. (2009). The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist. Blood Coagulation & Fibrinolysis. 20(4). 271–275. 19 indexed citations

13.

Connor, Philip, Kate Khair, Ri Liesner, et al.. (2008). Stem cell transplantation for children with Glanzmann thrombasthenia. British Journal of Haematology. 140(5). 568–571. 22 indexed citations

14.

Connor, Philip, Paul Veys, Persis Amrolia, et al.. (2008). PULMONARY HYPERTENSION IN CHILDREN WITH EVANS SYNDROME. Pediatric Hematology and Oncology. 25(2). 93–98. 12 indexed citations

15.

Connor, Philip, et al.. (2008). Cardiopulmonary bypass for surgical correction of congenital heart disease in children with sickle cell disease: a case series. Anaesthesia. 63(6). 648–651. 13 indexed citations

16.

Connor, Philip, et al.. (2008). Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy. Bone Marrow Transplantation. 42(4). 253–257. 6 indexed citations

17.

Connor, Philip & Beverley J. Hunt. (2003). Cerebral haemostasis and antiphospholipid antibodies. Lupus. 12(12). 929–934. 7 indexed citations

18.

Ampil, Federico L., et al.. (2001). Can intermediate-risk node-negative patients with stage I corpus cancer do without posthysterectomy radiotherapy? Review of a 13-year experience.. PubMed. 22(4). 269–72. 2 indexed citations

19.

Russell, Michael A., J A Stapleton, C Feyerabend, et al.. (1993). Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.. BMJ. 306(6888). 1308–1312. 138 indexed citations

20.

Montgomery, Stuart, et al.. (1992). Dose Response Relationship of Citalopram 20 mg, Citalopram 40 mg and Placebo in the Treatment of Moderate and Severe Depression. International Clinical Psychopharmacology. 6. 65–70. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact